Allogeneic stem cell mobilisation
ISRCTN | ISRCTN94372129 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN94372129 |
Secondary identifying numbers | Rostock01 |
- Submission date
- 25/11/2011
- Registration date
- 30/03/2012
- Last edited
- 17/10/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Surgery
Plain English summary of protocol
Background and study aims
Stem cell mobilization is a process where drugs are used to cause the movement of stem cells so that they can be collected and used for a stem cell transplant. The drug ratiograstim has been approved for the mobilization of peripheral stem cells (from the bloodstream). The aim of this study is to assess the effectiveness and safety of peripheral stem cell mobilization by either ratiograstim or the reference drug G-CSF.
Who can participate?
Patients undergoing a stem cell transplant for hematological malignancies (cancers that affect the blood and lymph system) and their related healthy donors
What does the study involve?
Participating donors are treated with either ratiograstim or G-CSF and the effectiveness and safety of the two drugs is compared.
What are the possible benefits and risks of participating?
Not provided at time of registration
Where is the study run from?
Universität Heidelberg (Germany)
When is the study starting and how long is it expected to run for?
January 2010 to November 2011
Who is funding the study?
Ratiopharm GmbH (Germany)
Who is the main contact?
Prof. Michael Schmitt
Contact information
Scientific
Universität Heidelberg
Hämatologie
Grabengasse 1
Heidelberg
69120
Germany
Study information
Study design | Non-randomised trial |
---|---|
Primary study design | Interventional |
Secondary study design | Non randomised study |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please contact mathias.freund@onkologie-rostock.de to request a patient information sheet |
Scientific title | Application of the granulocyte colony-stimulating factor (G-CSF) biosimilar ratiograstim for the mobilisation of peripheral stem cells in healthy donors |
Study objectives | Effectivity of the biosimilar ratiograstim is similar to original G-CSF. |
Ethics approval(s) | Federal Authority (Bundesamt für Arzneimittel, BfArM), 21/07/2010, ref: SNR: 250906/10 |
Health condition(s) or problem(s) studied | Allogeneic stem cell transplantation |
Intervention | Two cohorts, one cohort of 11 patients and donors receiving the biosimilar Ratiograstim® versus another cohort of 11 patients and donors receiving reference G-CSF. Results in this study arm were compared with results of a matched historical control |
Intervention type | Procedure/Surgery |
Primary outcome measure | Efficacy in peripheral stem cell mobilisation |
Secondary outcome measures | Safety in peripheral stem cell mobilisation |
Overall study start date | 01/01/2010 |
Completion date | 30/11/2011 |
Eligibility
Participant type(s) | Mixed |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 22 |
Key inclusion criteria | 1. Donors had no known allergy to G-CSF 2. Siblings (match-related donors) |
Key exclusion criteria | Younger than 18 years |
Date of first enrolment | 01/01/2010 |
Date of final enrolment | 30/11/2011 |
Locations
Countries of recruitment
- Germany
Study participating centre
69120
Germany
Sponsor information
University/education
c/o Prof. Dr. med. michael schmitt
Hämatologie
Grabengasse 1
Heidelberg
69117
Germany
https://ror.org/038t36y30 |
Funders
Funder type
Industry
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/07/2013 | Yes | No |
Editorial Notes
17/10/2017: Plain English summary and publication reference added.